|
Volumn 25, Issue 8, 2001, Pages 673-680
|
The final phase in acute myeloid leukaemia (AML): A study of cause of death, place of death and type of care during the last week of life
b
TNO
(Netherlands)
|
Author keywords
Acute leukaemia; Cost effectiveness; Elderly; Intensive treatment; Palliative care; Palliative medicine; Quality of life
|
Indexed keywords
ANTIBIOTIC AGENT;
ANTIFUNGAL AGENT;
CYTOSTATIC AGENT;
ACUTE GRANULOCYTIC LEUKEMIA;
ADULT;
AGED;
APLASIA;
ARTICLE;
BONE MARROW TRANSPLANTATION;
BRAIN HEMORRHAGE;
CANCER STAGING;
CAUSE OF DEATH;
COST EFFECTIVENESS ANALYSIS;
DEATH CERTIFICATE;
DECISION MAKING;
DRUG USE;
DYING;
FEMALE;
HEALTH CARE;
HEART FAILURE;
HEMODIALYSIS;
HUMAN;
INFECTION;
LUNG DISEASE;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL RECORD;
MULTIPLE ORGAN FAILURE;
PAIN;
PALLIATIVE THERAPY;
PARENTERAL NUTRITION;
PNEUMONIA;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RETROSPECTIVE STUDY;
SEPTICEMIA;
STROKE;
SWEDEN;
ACUTE DISEASE;
ADULT;
AGED;
AGED, 80 AND OVER;
ATTITUDE TO DEATH;
BONE MARROW TRANSPLANTATION;
CAUSE OF DEATH;
DEATH;
FEMALE;
HUMANS;
LEUKEMIA, MYELOID;
MALE;
MIDDLE AGED;
PALLIATIVE CARE;
RETROSPECTIVE STUDIES;
TERMINAL CARE;
|
EID: 0035001179
PISSN: 01452126
EISSN: None
Source Type: Journal
DOI: 10.1016/S0145-2126(01)00005-4 Document Type: Article |
Times cited : (24)
|
References (15)
|